Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first ...

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for conditions ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Xanax, marijuana, Benadryl and Flexeril were also found in her system ... had she not had the pre-existing heart disease and cocaine use, she may not have drowned,” Craig Harvey, the Los ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...

If you're chronically achy, these moves and meds can provide reliefGentle exercise can help reduce back pain and prevent ...

In December, Tonix announced that the U.S. Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025, for a decision on marketing authorization ...

It has the most postmarketing surveillance data of any of the currently used antiemetic agents ... F Droperidol 0.625 mg i.v., cyclobenzaprine 10 mg po, fluoxetine, HCTZ/triamterene, amlodipine ...

The Department of Homeland Security unveiled a list of artificial intelligence uses that are prohibited for agency missions as part of a new directive quietly introduced this week. The directive, ...